Navigation Links
Lunging to Death: Lung Anomalies in Infants Enhance Cot Death Risk

SIDS or sudden infant death syndrome has been the cause of many infant deaths, which has led many parents to ensure the baby sleeps on its back. In a bid to investigate the// latent tendencies that make the infant vulnerable, researchers discovered that infants born with an anomaly in three lungs related genes were prone to the risk of SIDS.

The study has undoubtedly made it easier to peg those infants at risk and enable a closer observation of such babies, and avert potential cot death. Following up on the earlier discovery of a connection between variants of a gene called Interleukin 10 (IL-10), scientists were able to find two other genes in the immune system, Interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) – which contribute in great measure to the baby's risk.

The three genes in question are responsible for producing chemicals, called cytokines that maintain the efficacy of the immune system. When there are specific variants of the Inter leukin genes, it causes the immune system in the affected child to behave erratically in response to a bacterial infection, which could result in SIDS. The variant in the gene could also retrograde the lung development, making it a lethal proposition for the affected babies.

Dr David Drucker, who led the study, said: "This research greatly advances our understanding of the basic causes of SIDS, which is not a single disease but a collection of different causes of death.Being able to detect high-risk babies means that health care and social provision can be aimed at the most vulnerable infants. In theory, commercially available and licensed human immune serum could be given to those children most at risk."

Other risk factors of SIDS include premature birth, low birth weight, exposure to cigarette smoke before and after birth.
'"/>




Page: 1

Related medicine news :

1. Sudden Cardiac Death: Diabetes May Be The Culprit
2. Life Or Death: Parents Await High Court Judgment
3. Children With Facial Anomalies Are Affected By Parental Tensions
4. Druggists On Strike In Jharkhand To Protest Against VAT Anomalies
5. NSAIDs In First trimester Linked To Congenital Anomalies In Babies
6. Special Section of JCS Addresses Vascular Anomalies
7. Banning Smoking in the Home Helps Infants
8. Benefits of Nitric Oxide in the Treatment of Premature Infants
9. New Technique to Study Infants Brain.
10. Limiting Infants Exposure To Smoke At Home
11. fMRI Offers Insight Into An Infants Brain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... ... Excellence (CoE) with the latest Artificial Intelligence (AI) thinking, announced today the launch ... and easy access to essential information that offers a more comprehensive understanding of ...
(Date:9/20/2017)... ... September 20, 2017 , ... Renal ... for people who have kidney disease. The theme “Describe a positive decision that ... Entrants needed to meet only one qualification— to have been diagnosed with ...
(Date:9/20/2017)... Houston, TX (PRWEB) , ... September 20, 2017 ... ... the date of the much-anticipated fall event , Look Awesome This Autumn ... demonstrations, personalized consultations, special pricing and refreshments. , Mirror Mirror Beauty Boutique ...
(Date:9/20/2017)... ... September 20, 2017 , ... As part of ... recently unveiled a redesigned website. The new site – still located at ... architects, contractors and other industry users that Garland serves. , After an ambitious ...
(Date:9/20/2017)... ... September 20, 2017 , ... In just a short time since going on ... positive feedback from customers trying the product for the first time, and others who ... developed by neurosurgeon Shawn Moore, MD, for everyone from athletes at risk from multiple ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017  For nearly two decades, New Life Agency has been committed ... industry. Today, New Life Agency announces a powerful three-way partnership designed to ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/7/2017)...   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade cell and tissue hypothermic storage and ... , President and CEO, will be presenting at two investment ... Renshaw 19 th Annual Global Investment Conference on Tuesday, ... time). The conference is being held at the New York ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
Breaking Medicine Technology: